Qid^® enables women and healthcare professionals to access non-invasively and verify breast implant details quickly from any* geographical location, thus overcoming previous challenges with implant traceability and potentially avoiding unnecessary surgical procedures.

The ability to easily access and verify implant information has proven difficult for many women due to a lack of reliable breast implant registries, loss of medical records, loss of patient device cards, surgeon relocation and a significant increase in cosmetic tourism.^7,8 Further, many women state they have never received their implant information post-surgery.⁹

Additionally, implants with microtransponders such as Qid^® allow patients and healthcare practitioners to to check for counterfeits or devices different to the ones agreed upon for implantation, through non-invasive verification of the exact device information including brand, model, size, serial number and manufacturing date.

Moreover, verifying the previously implanted device prior to revision surgery can enhance the surgeon’s preoperative planning by ensuring full awareness of key implant characteristics, including surface type, volume, and shape. This information may also assist in planning capsule management by identifying the implant surface. The Food and Drug Administration (FDA) has further acknowledged the importance of radiologists being aware of the breast implant fill material(s), number of lumens, manufacturer, and model to support accurate interpretation and diagnosis during imaging surveillance.^10,11 With Qid^®, this information can be easily accessed.¹²

Qid^® utilizes passive RFID technology, meaning it does not contain a battery.

Instead, its functionality relies on the connection to the Motiva^® Reader - a proprietary handheld radiofrequency reader. When the reader is brought near the implant, it emits power that activates the component’s integrated circuit. This circuit then transmits a unique electronic serial number (ESN) via radio waves. Qid^® transmits a 15-digit ESN.

Each ESN is unique to the individual implant and can be securely entered by a certified Motiva^® surgeon into the motiva.health professional database to retrieve implant information.^1-3

Qid^® provides the external handheld reader only with the implant’s unique ESN (15-digits). Once the ESN is entered into the motiva.health database, an authorized surgeon can retrieve specific implant information, including surface type, style, size, manufacturing date, and procedure information.^1,2

Growing awareness of breast implant–associated conditions (particularly breast implant–associated anaplastic large-cell lymphoma) has highlighted the importance of patients knowing and verifying the specific type and characteristics of their breast implants. Certain implant features have been associated with differing levels of risk, making accurate implant identification important for appropriate monitoring and clinical decision-making.^14-16

Reliable implant information is also important in the context of manufacturer safety notifications, regulatory updates, or device recalls.¹⁷ In these situations, patients and clinicians rely on accurate implant identification to guide decisions related to surveillance, continued implantation, or explantation.

Previous implant-related safety events have shown that concern may arise even in the absence of symptoms or confirmed device-related complications. In some cases, anxiety and uncertainty, rather than clinical indication, have led patients to choose prophylactic explantation (preventive implant removal).¹⁸ Access to accurate, verifiable implant information after surgery (as with Qid^®) can help support informed discussions and reduce uncertainty when decisions are being made.

Measuring 9mm x 2mm, aproximately the size of a rice kernel, Qid^® consists of an integrated circuit and a receiving/transmitting antenna tightly wrapped around a nickel-zinc ferrite core, encapsulated in biocompatible glass.

The safety of Qid^® has been thoroughly tested following International Organization of Standardization¹⁹ (ISO) 10993-1, FDA Guidance²⁰, and tested by North American Science Associate (NAMSA) to ensure it meets all safety standards.²¹ These safety standards include the biological evaluation, chemical characterization, and toxicological assessment of Motiva Implants^® with the optional microtransponder.²²

Qid^® is embedded within the highly-cohesive silicone gel,²³ on the posterior aspect of the implant. Post-market surveillance data has shown no reported cases of RFID migration into the surrounding breast tissue.²⁴

In the event of an implant rupture, a complete chemical characterization and biocompatibility assessment of Qid^® have been conducted, followed by a subsequent toxicological evaluation, and the results demonstrated that the Qid^® is non-cytotoxic and safe for clinical use.²¹

Women with Motiva Implants^® featuring Qid^® can safely undergo the following breast imaging modalities: ^25-27

• Mammography,
• Computerized tomography (CT),
• X-ray,
• Ultrasound,
• MRI, under specific conditions.

All patients with Motiva Implants^® can safely undergo Magnetic Resonance (MR) scanning. Potential image distortions caused by a Qid^® microtransponder can be effectively managed using existing MRI guidelines or alternative imaging types.

Motiva Implants^® with RFID are labeled MR Conditional, meaning that patients with this RFID technology can safely undergo MRI under specific conditions^*:²

• Static magnetic field of 1.5-Tesla and 3-Tesla only
• Maximum Spatial Gradient Magnetic Field: Up to 4,000-gauss/cm (40-T/m), extrapolated.
• Specific Absorption Rate (SAR): Whole-body averaged SAR of 2 W/kg for: 15 minutes of scanning (i.e., per pulse sequence), or 60 minutes of continuous scanning (i.e., per pulse sequence or back-to-back sequences/series without breaks) in the Normal Operating Mode.

*Refer to the Directions of Use for complete MRI guidance.

You can check whether your Motiva^® implants include RFID technology such as with Qid^® by looking at the catalogue or reference number on your Motiva^® Implant Card.

• If the number ends with the letter “Q”, your implants include Qid^®.
• If there are no letters present, it means that RFID technology is not included in your breast implants.

No, Qid^® is a passive device with no battery. Qid^® responds a signal only when activated by the specific radio frequency of the Motiva^® Reader, in contrast to “tracking” devices that continuously emit signals.¹³

The only information transmitted from the Qid^® to the Motiva^® Reader is the 15-digit electronic serial number (ESN), which is accessible only by certified healthcare professionals when the Motiva^® Reader is placed near the implant. Entering the ESN into the motiva.health database, allows access to specific implant information, including surface type, projection, base, volume, and manufacturing date.